Moderna requests emergency use authorization for COVID-19 vaccine in young kids
Moderna requests emergency use authorization from the FDA for its vaccine for children as young as six-months-old.
Moderna requests emergency use authorization from the FDA for its vaccine for children as young as six-months-old.
Moderna is asking U.S. regulators to open its COVID-19 vaccine to the nation’s youngest children. Kids under 5 are the only group in the U.S. not yet eligible for vaccination.
Health care providers hoping to get new guidance on coronavirus vaccines from the FDA will have to keep waiting. Wednesday’s meeting ended with no solid answers regarding the future of booster shots and regular vaccines.
Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers.
Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness.
U.S. regulators are shortening the time that people who received Moderna’s COVID-19 vaccine have to wait for a booster – to five months rather than six.
Moderna said Monday that a booster dose of its COVID-19 vaccine should offer protection against the rapidly spreading omicron variant.
The CDC has updated its recommendations on COVID-19 vaccines after its vaccine advisors met on Thursday. This comes as the Omicron variant continues to spread in the U.S.
Data is still coming in on vaccines versus the Omicron variant.
“I don’t want to hit the panic button but we are strongly encouraging South Carolinians to continue the safety protocols that helped us drive the numbers down from that high point back in September,” Traxler said.